{
  "id": 2309622,
  "title": "FDA records GH¢70m surplus in 2025 amid concerns over ageing lab equipment",
  "url": "https://urgent.news/2026/08/21/fda-records-gh-70m-surplus-in-2025-amid-concerns-over-ageing-lab",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-21T05:28:20.000Z",
  "source": {
    "name": "MyJoyOnline Ghana",
    "slug": "myjoyonline-ghana",
    "url": "https://www.myjoyonline.com/fda-records-gh%c2%a270m-surplus-in-2025-amid-concerns-over-ageing-lab-equipment/"
  },
  "original_language": "en",
  "account": "In 2025, the Food and Drugs Authority (FDA) recorded a surplus of GH¢70 million, marking a 51% increase from the previous year's GH¢46 million surplus. This financial growth, however, was overshadowed by operational challenges such as aging laboratory equipment and the circulation of illicit products. FDA Deputy Director of Finance, Samuel Adom-Siaw, revealed these figures during the FDA's 2025 Annual Stakeholders' Meeting in Accra, alongside its audited financial statements. The Authority's total assets expanded from GH¢296 million in 2024 to GH¢358 million in 2025, while its liabilities dwindled from GH¢12 million to GH¢3.4 million. The FDA's total revenue reached GH¢420 million for the year, consisting of GH¢278 million from internally generated funds, GH¢78 million from donor support, and GH¢63 million from government subsidies. Internally generated funds accounted for 66% of the total revenue, followed by donor inflows at 19% and government subsidies at 15%. Despite higher staff compensation and increased operational requirements, expenditure rose only marginally from GH¢266 million to GH¢267 million. However, the Authority faced a GH¢95 million shortfall against its projected IGF target of GH¢374 million, attributed largely to exchange-rate movements. To address revenue mobilisation and control expenditure, the FDA plans to review its fees in consultation with stakeholders. On regulatory activities, FDA Quality Assurance Manager Joseph Ofosu-Siaw reported that the Authority processed 24,225 product applications, approving 20,205, conducting 15,457 facility inspections, examining 47,189 consignments at ports, and performing 2,250 market surveillance exercises. Notably, 215,876 non-compliant products were retrieved. Ofosu-Siaw highlighted that 62% of registered products were locally manufactured, up from 33% in 2024. However, he identified aging laboratory equipment as a significant concern, with some machines between eight and 20 years old, making maintenance increasingly difficult, especially in facilities operating 24/7.",
  "summary": "The Food and Drugs Authority (FDA) recorded a surplus of GH¢70 million in 2025, representing a 51 per cent increase from the GH¢46 million recorded in the previous year, despite operational challenges including ageing laboratory equipment and the circulation of illicit products.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "MyJoyOnline Ghana",
        "title": "FDA records GH¢70m surplus in 2025 despite laboratory equipment, illicit product concerns",
        "url": "https://urgent.news/2026/08/20/fda-records-gh-70m-surplus-in-2025-despite-laboratory-equipment",
        "published": "2026-08-20T13:31:22.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}